MONTREAL, Oct. 14, 2004 (PRIMEZONE) -- Viropro, Inc. (OTCBB:VPRO) announced today that it has appointed Mr. Serge Beausoleil as President of its newly-created Canadian subsidiary, Viropro Canada. In this new capacity, Mr. Beausoleil will be assuming responsibility for day-to-day operations as the company pursues its aggressive expansion program.
In making this appointment, Viropro plans to dramatically accelerate its thrust into the Biotech market and anticipates announcing appointments to its Board of Directors, Scientific Advisory Council, as well as significant product and market agreements, in the very near future. It is anticipated that Mr. Beausoleil, as a further part of his mandate, will appoint a successor to his position in due course once the necessary structures and resources are in place to fuel the Company's next stage of development in its target markets.
Mr. Beausoleil brings over 15 years pertinent experience in financial services and developing business solutions across multiple sectors, with particular strength in creating successful partnership agreements, strategic alliances and financial structures. He holds a Science Masters in economics and management and a Bachelor's degree in business management.
"I am delighted to be joining Viropro at this critical point in its development," commented Mr. Beausoleil. "The atmosphere is vibrant and the tools are in place to begin rapidly implementing our strategic plan for building a portfolio of world-class products and growth companies with core competencies in the Life Sciences sector."
About Viropro, Inc.
Viropro, Inc. (OTCBB:VPRO) is seeking to establish a growth portfolio in Life Sciences markets through strategic alliances and revenue-producing acquisitions with the potential for continued shareholder value.
Viropro, Inc's Safe Harbor Statement
Except for any historic information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, which are subject to section 27A of the Securities Act of 1933 and section 21E of the Exchange Act of 1934, and are subject to safe harbor created by these sections. Any statements that express or involve discussions with respect to predictions, beliefs, plans, projections, objectives, goals, assumptions of future events or performances are not statements of historical fact and may be "forward looking statements". Forward looking statements in this release may be identified through the use of such words as "expects", "anticipates", "estimates", "believes", or statements indicating certain actions "may", "could", or "might" occur. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements, which involve numerous risks and uncertainties, including the Company's ability to market its products and services in a competitive environment as well as other factors.